Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Transpl Infect Dis ; 7(3-4): 146-9, 2005.
Article in English | MEDLINE | ID: mdl-16390404

ABSTRACT

Candida dubliniensis is an emerging opportunistic yeast initially identified as a cause of oropharyngeal candidiasis in human immunodeficiency virus-infected individuals, and recently associated with invasive disease in other immunocompromised hosts. Certain diagnostic characteristics are shared with C. albicans, but differences in epidemiology, microbiology, and potentially clinical management are notable. We report a case of fatal C. dubliniensis bloodstream infection in a solid-organ transplant recipient and review the literature.


Subject(s)
Candida/classification , Candida/isolation & purification , Fungemia/microbiology , Lung Transplantation/adverse effects , Adult , Candida/genetics , Candidiasis/diagnosis , Candidiasis/microbiology , Cystic Fibrosis/complications , Fatal Outcome , Fungemia/diagnosis , Humans , Male
2.
Clin Infect Dis ; 31(3): 824-5, 2000 Sep.
Article in English | MEDLINE | ID: mdl-11017842

ABSTRACT

Neutropenia is an uncommon adverse effect associated with prolonged vancomycin therapy. Neutrophil counts normally recover after discontinuation of vancomycin in this situation, but treatment options are needed for those patients who require ongoing antibiotic therapy. We describe a case of vancomycin-induced neutropenia in which the neutropenia resolved after vancomycin was replaced by the structurally related compound teicoplanin.


Subject(s)
Anti-Bacterial Agents/adverse effects , Neutropenia/chemically induced , Teicoplanin/therapeutic use , Vancomycin/adverse effects , Adult , Anti-Bacterial Agents/therapeutic use , Humans , Male , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effects , Vancomycin/therapeutic use
3.
J Clin Microbiol ; 37(7): 2343-5, 1999 Jul.
Article in English | MEDLINE | ID: mdl-10364610

ABSTRACT

Amphotericin B therapy continues to be the "gold standard" in the treatment of invasive aspergillosis in the immunocompromised host. Although Aspergillus fumigatus and Aspergillus flavus constitute the major species, several reports have described invasive pulmonary or disseminated disease due to the less common Aspergillus terreus and dismal clinical outcomes with high-dose amphotericin B. We therefore evaluated 101 clinical isolates of A. terreus for their susceptibility to amphotericin B and the investigational triazole voriconazole by using the National Committee for Clinical Laboratory Standards M27-A method modified for mould testing. Forty-eight-hour MICs indicated 98 and 0% resistance to amphotericin B and voriconazole, respectively. We conclude that A. terreus should be added to the list of etiologic agents refractory to conventional amphotericin B therapy and suggest the potential clinical utility of voriconazole in aspergillosis due to this species.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Aspergillus/drug effects , Drug Resistance, Microbial , Pyrimidines/pharmacology , Triazoles/pharmacology , Amphotericin B/pharmacokinetics , Amphotericin B/therapeutic use , Antifungal Agents/pharmacokinetics , Antifungal Agents/therapeutic use , Aspergillosis/drug therapy , Aspergillosis/microbiology , Aspergillus/isolation & purification , Humans , Microbial Sensitivity Tests , Pyrimidines/pharmacokinetics , Treatment Outcome , Triazoles/pharmacokinetics , Voriconazole
4.
J Clin Microbiol ; 37(6): 1846-51, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10325335

ABSTRACT

Invasive fungal disease often plays an important role in the morbidity and mortality of immunocompromised patients. The poor sensitivity of current fungal blood culture and histological practices has led to the development of highly sensitive and specific molecular techniques, such as the PCR. Sequence variability of the internal transcribed spacer 2 (ITS2) region of fungi is potentially useful in rapid and accurate diagnosis of clinical fungal isolates. PCR with fungus-specific primers targeted toward conserved sequences of the 5.8S and 28S ribosomal DNA (rDNA) results in amplification of the species-specific ITS2 regions, which are variable in amplicon length. We have made use of the ABI PRISM 310 genetic analyzer and the ABI PRISM 310 GeneScan analysis software for the determination of variable size differences of the ITS2 region of clinically important fungi, including Candida and non-Candida yeasts, Aspergillus species, and a variety of dermatophytes. No cross-reaction occurred when samples were tested against human and bacterial genomic DNA. We have found that most clinically significant fungal isolates can be differentiated by this method, and it therefore serves to be a promising tool for the rapid (<7 h) diagnosis of fungemia and other invasive fungal infections.


Subject(s)
DNA, Ribosomal/genetics , Fungi/classification , Fungi/genetics , Genes, Fungal , Aspergillus/classification , Aspergillus/genetics , Base Sequence , Candida/classification , Candida/genetics , Candida albicans/classification , Candida albicans/genetics , Conserved Sequence , DNA, Fungal/genetics , DNA, Ribosomal/chemistry , Electrophoresis/methods , Fungi/isolation & purification , Humans , Mycoses/blood , Mycoses/diagnosis , Polymerase Chain Reaction/methods , RNA, Fungal/genetics , RNA, Ribosomal, 28S/genetics , RNA, Ribosomal, 5.8S/genetics , Sensitivity and Specificity
5.
J Clin Microbiol ; 37(1): 195-8, 1999 Jan.
Article in English | MEDLINE | ID: mdl-9854089

ABSTRACT

Metarrhizium anisopliae is a common pathogen of insects and has even been used to control insect populations. It is rarely isolated from human or animal sources, but recently, there have been three reported cases of disease, two in humans and one in a cat. We present our experience with five isolates from human sources, including two that were the apparent causes of two cases of sinusitis in immunocompetent hosts. The first patient was a 36-year-old male with frontal and ethmoid sinusitis, and the second was a 79-year-old female with chronic sinusitis. Both patients underwent surgery, and pathology of the surgical specimens revealed branching hyphae. Cultures grew only Metarrhizium species. Neither patient received antifungal therapy, and both did well postoperatively. The other three isolates were cultured from bronchoalveolar lavage specimens but were not felt to be clinically significant. Antifungal susceptibility testing using the National Committee for Clinical Laboratory Standards macrobroth method revealed that all isolates were resistant to amphotericin B, 5-flucytosine, and fluconazole. Itraconazole and newer azole compounds were more active. Metarrhizium species may cause disease in humans, even those without evidence of immunosuppression, and are apparently highly resistant to amphotericin B in vitro.


Subject(s)
Mitosporic Fungi , Mycoses/microbiology , Sinusitis/microbiology , Adult , Aged , Antifungal Agents/pharmacology , Female , Humans , Immunocompetence , Male , Microbial Sensitivity Tests , Middle Aged , Mitosporic Fungi/drug effects , Mitosporic Fungi/isolation & purification , Mitosporic Fungi/pathogenicity , Mycoses/immunology , Sinusitis/immunology
6.
J Clin Microbiol ; 36(10): 3007-12, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9738058

ABSTRACT

Candida dubliniensis has been associated with oropharyngeal candidiasis in patients infected with human immunodeficiency virus (HIV). C. dubliniensis isolates may have been improperly characterized as atypical Candida albicans due to the phenotypic similarity between the two species. Prospective screening of oral rinses from 63 HIV-infected patients detected atypical dark green isolates on CHROMagar Candida compared to typical C. albicans isolates, which are light green. Forty-eight atypical isolates and three control strains were characterized by germ tube formation, differential growth at 37, 42, and 45 degreesC, identification by API 20C, fluorescence, chlamydoconidium production, and fingerprinting by Ca3 probe DNA hybridization patterns. All isolates were germ tube positive. Very poor or no growth occurred at 42 degreesC with 22 of 51 isolates. All 22 poorly growing isolates at 42 degreesC and one isolate with growth at 42 degreesC showed weak hybridization of the Ca3 probe with genomic DNA, consistent with C. dubliniensis identification. No C. dubliniensis isolate but only 18 of 28 C. albicans isolates grew at 45 degreesC. Other phenotypic or morphologic tests were less reliable in differentiating C. dubliniensis from C. albicans. Antifungal susceptibility testing showed fluconazole MICs ranging from

Subject(s)
AIDS-Related Opportunistic Infections/diagnosis , Antifungal Agents/pharmacology , Candida/classification , Candidiasis, Oral/diagnosis , HIV Infections/complications , AIDS-Related Opportunistic Infections/drug therapy , AIDS-Related Opportunistic Infections/microbiology , Amphotericin B/pharmacology , Antifungal Agents/therapeutic use , Candida/drug effects , Candida/genetics , Candidiasis, Oral/drug therapy , Candidiasis, Oral/etiology , Fluconazole/pharmacology , Genotype , Humans , Itraconazole/pharmacology , Microbial Sensitivity Tests , Mouth/microbiology , North America , Pharynx/microbiology , Phenotype , Pyrimidines/pharmacology , Triazoles/pharmacology , Voriconazole
SELECTION OF CITATIONS
SEARCH DETAIL
...